Related Experiment Videos
Opsonin system of the group B streptococcus
Infection and Immunity
|December 1, 1974
Summary
Group B Streptococcus serotype BIa poses a significant risk for neonatal sepsis due to poor opsonization. Other serotypes are naturally opsonized, suggesting distinct immune evasion strategies.
Area of Science:
- Immunology
- Microbiology
- Neonatal Health
Background:
- Group B Streptococcus (GBS) serotypes are a leading cause of neonatal sepsis and meningitis.
- Opsonization by polymorphonuclear leukocytes is crucial for bacterial clearance.
- Specific antibodies are required for effective opsonization of certain GBS serotypes, like BIa.
Purpose of the Study:
- To investigate the opsonization mechanisms of different GBS serotypes.
- To identify antibodies involved in the opsonization of GBS serotype BIa.
- To understand the role of complement in GBS opsonization.
Main Methods:
- Assessing opsonization and phagocytic activity in human, baboon, and rabbit sera.
- Utilizing macroagglutination and absorption assays to determine antibody specificity.
- Investigating complement pathways (classic and alternative) involved in opsonization.
Main Results:
- Serotype BIa was poorly opsonized without a specific antibody, found in only 10% of the population.
- The specific BIa opsonizing antibody enhanced phagocytic activity by 60% via complement.
- Serotypes BIb, BIc, BII, and BIII were efficiently opsonized in 95% of sera tested, independent of specific antibodies.
Conclusions:
- GBS serotype BIa presents a high mortality risk in neonates due to inefficient opsonization.
- The lack of specific antibodies against BIa contributes to its virulence.
- Distinct opsonization mechanisms for different GBS serotypes may influence disease presentation, such as meningitis caused by BIII.